vs

Side-by-side financial comparison of Everus Construction Group, Inc. (ECG) and NORTHERN OIL & GAS, INC. (NOG). Click either name above to swap in a different company.

Everus Construction Group, Inc. is the larger business by last-quarter revenue ($1.0B vs $610.2M, roughly 1.7× NORTHERN OIL & GAS, INC.). Everus Construction Group, Inc. runs the higher net margin — 5.5% vs -11.6%, a 17.1% gap on every dollar of revenue. On growth, Everus Construction Group, Inc. posted the faster year-over-year revenue change (33.2% vs -72.6%). NORTHERN OIL & GAS, INC. produced more free cash flow last quarter ($43.2M vs $23.5M). Over the past eight quarters, Everus Construction Group, Inc.'s revenue compounded faster (27.1% CAGR vs 4.3%).

Marathon Oil Corporation was an American company engaged in hydrocarbon exploration. In November 2024, it was acquired by ConocoPhillips and absorbed into the company.

ECG vs NOG — Head-to-Head

Bigger by revenue
ECG
ECG
1.7× larger
ECG
$1.0B
$610.2M
NOG
Growing faster (revenue YoY)
ECG
ECG
+105.7% gap
ECG
33.2%
-72.6%
NOG
Higher net margin
ECG
ECG
17.1% more per $
ECG
5.5%
-11.6%
NOG
More free cash flow
NOG
NOG
$19.7M more FCF
NOG
$43.2M
$23.5M
ECG
Faster 2-yr revenue CAGR
ECG
ECG
Annualised
ECG
27.1%
4.3%
NOG

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ECG
ECG
NOG
NOG
Revenue
$1.0B
$610.2M
Net Profit
$55.3M
$-70.7M
Gross Margin
11.6%
Operating Margin
6.8%
Net Margin
5.5%
-11.6%
Revenue YoY
33.2%
-72.6%
Net Profit YoY
60.4%
-198.7%
EPS (diluted)
$1.09
$-0.73

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ECG
ECG
NOG
NOG
Q1 26
$610.2M
Q4 25
$1.0B
$610.2M
Q3 25
$986.8M
$556.6M
Q2 25
$921.5M
$706.8M
Q1 25
$826.6M
$602.1M
Q4 24
$759.6M
$515.0M
Q3 24
$761.0M
$753.6M
Q2 24
$703.4M
$560.8M
Net Profit
ECG
ECG
NOG
NOG
Q1 26
$-70.7M
Q4 25
$55.3M
$-70.7M
Q3 25
$57.0M
$-129.1M
Q2 25
$52.8M
$99.6M
Q1 25
$36.7M
$139.0M
Q4 24
$34.5M
$71.7M
Q3 24
$41.8M
$298.4M
Q2 24
$39.0M
$138.6M
Gross Margin
ECG
ECG
NOG
NOG
Q1 26
Q4 25
11.6%
80.4%
Q3 25
12.6%
78.7%
Q2 25
13.0%
82.8%
Q1 25
11.2%
81.1%
Q4 24
11.4%
77.4%
Q3 24
11.8%
85.8%
Q2 24
12.6%
82.0%
Operating Margin
ECG
ECG
NOG
NOG
Q1 26
Q4 25
6.8%
-5.5%
Q3 25
7.3%
-22.6%
Q2 25
7.9%
24.9%
Q1 25
6.2%
38.1%
Q4 24
6.1%
25.8%
Q3 24
7.1%
57.6%
Q2 24
7.3%
39.0%
Net Margin
ECG
ECG
NOG
NOG
Q1 26
-11.6%
Q4 25
5.5%
-11.6%
Q3 25
5.8%
-23.2%
Q2 25
5.7%
14.1%
Q1 25
4.4%
23.1%
Q4 24
4.5%
13.9%
Q3 24
5.5%
39.6%
Q2 24
5.5%
24.7%
EPS (diluted)
ECG
ECG
NOG
NOG
Q1 26
$-0.73
Q4 25
$1.09
$-0.67
Q3 25
$1.11
$-1.33
Q2 25
$1.03
$1.00
Q1 25
$0.72
$1.39
Q4 24
$0.68
$0.71
Q3 24
$0.82
$2.96
Q2 24
$0.76
$1.36

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ECG
ECG
NOG
NOG
Cash + ST InvestmentsLiquidity on hand
$14.3M
Total DebtLower is stronger
$281.5M
Stockholders' EquityBook value
$629.8M
$2.1B
Total Assets
$1.7B
$5.4B
Debt / EquityLower = less leverage
0.45×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ECG
ECG
NOG
NOG
Q1 26
$14.3M
Q4 25
$14.3M
Q3 25
$31.6M
Q2 25
$25.9M
Q1 25
$33.6M
Q4 24
$8.9M
Q3 24
$553.0K
$34.4M
Q2 24
$7.8M
Total Debt
ECG
ECG
NOG
NOG
Q1 26
Q4 25
$281.5M
$2.4B
Q3 25
$285.1M
$2.3B
Q2 25
$288.6M
$2.4B
Q1 25
$292.1M
$2.3B
Q4 24
$295.6M
$2.4B
Q3 24
$2.0B
Q2 24
$1.9B
Stockholders' Equity
ECG
ECG
NOG
NOG
Q1 26
$2.1B
Q4 25
$629.8M
$2.1B
Q3 25
$573.0M
$2.2B
Q2 25
$514.4M
$2.4B
Q1 25
$460.2M
$2.4B
Q4 24
$422.6M
$2.3B
Q3 24
$453.3M
$2.3B
Q2 24
$490.0M
$2.1B
Total Assets
ECG
ECG
NOG
NOG
Q1 26
$5.4B
Q4 25
$1.7B
$5.4B
Q3 25
$1.6B
$5.5B
Q2 25
$1.5B
$5.7B
Q1 25
$1.4B
$5.7B
Q4 24
$1.3B
$5.6B
Q3 24
$1.3B
$5.1B
Q2 24
$4.7B
Debt / Equity
ECG
ECG
NOG
NOG
Q1 26
Q4 25
0.45×
1.13×
Q3 25
0.50×
1.05×
Q2 25
0.56×
0.98×
Q1 25
0.63×
0.96×
Q4 24
0.70×
1.02×
Q3 24
0.84×
Q2 24
0.91×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ECG
ECG
NOG
NOG
Operating Cash FlowLast quarter
$48.2M
$312.6M
Free Cash FlowOCF − Capex
$23.5M
$43.2M
FCF MarginFCF / Revenue
2.3%
7.1%
Capex IntensityCapex / Revenue
2.4%
31.5%
Cash ConversionOCF / Net Profit
0.87×
TTM Free Cash FlowTrailing 4 quarters
$90.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ECG
ECG
NOG
NOG
Q1 26
$312.6M
Q4 25
$48.2M
$312.6M
Q3 25
$76.2M
$423.1M
Q2 25
$25.3M
$362.1M
Q1 25
$7.1M
$407.4M
Q4 24
$290.3M
Q3 24
$78.9M
$385.8M
Q2 24
$340.5M
Free Cash Flow
ECG
ECG
NOG
NOG
Q1 26
$43.2M
Q4 25
$23.5M
Q3 25
$65.7M
Q2 25
$12.3M
Q1 25
$-11.4M
Q4 24
Q3 24
$60.9M
Q2 24
FCF Margin
ECG
ECG
NOG
NOG
Q1 26
7.1%
Q4 25
2.3%
Q3 25
6.7%
Q2 25
1.3%
Q1 25
-1.4%
Q4 24
Q3 24
8.0%
Q2 24
Capex Intensity
ECG
ECG
NOG
NOG
Q1 26
31.5%
Q4 25
2.4%
Q3 25
1.1%
Q2 25
1.4%
Q1 25
2.2%
Q4 24
Q3 24
2.4%
Q2 24
Cash Conversion
ECG
ECG
NOG
NOG
Q1 26
Q4 25
0.87×
Q3 25
1.34×
Q2 25
0.48×
3.64×
Q1 25
0.19×
2.93×
Q4 24
4.05×
Q3 24
1.89×
1.29×
Q2 24
2.46×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ECG
ECG

Commercial$594.5M59%
Utility$203.5M20%
Industrial$82.8M8%
Institutional$66.1M7%
Service And Other$28.4M3%
Transportation$24.2M2%
Renewables$19.8M2%

NOG
NOG

Oil and Gas Sales$447.7M73%
Gain on Commodity Derivatives, Net$159.3M26%
Other Revenue$3.1M1%

Related Comparisons